Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in advanced transitional cell carcinoma
NCT00714025Phase 2Completed
- Start
- Nov 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in transitional cell carcinoma (TCC). Started Nov 2008; status: completed.
02
Drugs
everolimus
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on NCT00714025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00714025.